EUDAW
EUDA Health Holdings LimitedNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
0.68
52W High
$0.15
52W Low
$0.02
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-40.70%
Forward P/E
—
PEG Ratio
—
About EUDA Health Holdings Limited
EUDA Health Holdings Limited is a pioneering biotechnology firm dedicated to developing cutting-edge therapies for dermatological and chronic health conditions. With a strong emphasis on scientific innovation and technological integration, EUDA is committed to addressing significant unmet medical needs through its comprehensive pipeline of transformative products. Backed by a seasoned leadership team with extensive industry experience, the company is well-positioned to capitalize on growth opportunities in the rapidly evolving healthcare landscape, ultimately aimed at improving patient outcomes and enhancing quality of life.
Fundamentals
| Revenue (TTM) | $6.82M |
| Gross Profit (TTM) | $2.99M |
| EBITDA | $-2.24M |
| Operating Margin | -34.80% |
| Return on Equity | 0.00% |
| Return on Assets | -89.30% |
| Revenue/Share (TTM) | $3.65 |
| Book Value | $-2.25 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 78.90% |
| Shares Outstanding | 0 |
| Float | $1.11M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
Data last updated: 7/9/2026